ARTICLE | Clinical News
Salmon-calcitonin nasal spray regulatory update
December 22, 2008 8:00 AM UTC
FDA granted tentative approval to an ANDA from MDRNA for generic calcitonin-salmon nasal spray to treat osteoporosis. Final approval is expected in June 2009 after the expiration of a 180-day exclusi...